Bora Pharmaceuticals Co. Ltd (BORAY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | |
| Assets | ||
| Current Assets | ||
| Cash & Cash Equivalents | 162,968 | 181,288 |
| Receivables | 293,217 | 347,589 |
| Inventories | 109,475 | 171,123 |
| Other current assets | 33,395 | 14,513 |
| TOTAL | $620,737 | $732,893 |
| Non-Current Assets | ||
| PPE Net | 334,906 | 363,380 |
| Investments And Advances | 183,200 | 553 |
| Intangibles | 200,447 | 231,514 |
| Other Non-Current Assets | 96,035 | 89,787 |
| TOTAL | $814,588 | $685,234 |
| Total Assets | $1,435,325 | $1,418,127 |
| Liabilities | ||
| Current Liabilities | ||
| Short Term Debt | 54,277 | 36,979 |
| Accounts payable and accrued liabilities | 110,532 | 126,364 |
| Other current liabilities | 122,879 | 166,441 |
| TOTAL | $427,602 | $429,447 |
| Non-Current Liabilities | ||
| Long Term Debt | 378,661 | 445,473 |
| Other Non-Current Liabilities | 34,396 | 34,123 |
| TOTAL | $446,866 | $521,820 |
| Total Liabilities | $874,468 | $951,267 |
| Shareholders' Equity | ||
| Common Shares | 40,884 | 32,060 |
| Other shareholders' equity | 329,582 | 298,704 |
| TOTAL | $560,857 | $466,860 |
| Total Liabilities And Equity | $1,435,325 | $1,418,127 |